Kamada Ltd. develops, produces and markets specialty therapeutics, including specific immunoglobulins and other prescribed medicines, using sophisticated chromatographic purification technology. Utilizing its proprietary know-how, Kamada manufactures 10 high quality and highly safe biopharmaceuticals. Kamada flagship product - AAT, for the treatment of Congenital Emphysema - is approved for Phase III of clinical testing by the FDA, and is already administered in a number of countries. Kamada is...
more>>